- Home
- ARWR vs RNG Comparison
ARWR vs RNG Comparison
Compare ARWR & RNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- RNG
- Stock Information
- Founded
- ARWR 2003
- RNG 1999
- Country
- ARWR United States
- RNG United States
- Employees
- ARWR N/A
- RNG N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- RNG EDP Services
- Sector
- ARWR Health Care
- RNG Technology
- Exchange
- ARWR Nasdaq
- RNG Nasdaq
- Market Cap
- ARWR 1.7B
- RNG N/A
- IPO Year
- ARWR 1993
- RNG 2013
- Fundamental
- Price
- ARWR $11.24
- RNG $22.77
- Analyst Decision
- ARWR Buy
- RNG Buy
- Analyst Count
- ARWR 11
- RNG 13
- Target Price
- ARWR $41.44
- RNG $36.00
- AVG Volume (30 Days)
- ARWR 2.3M
- RNG 1.7M
- Earning Date
- ARWR 05-08-2025
- RNG 05-06-2025
- Dividend Yield
- ARWR N/A
- RNG N/A
- EPS Growth
- ARWR N/A
- RNG N/A
- EPS
- ARWR N/A
- RNG N/A
- Revenue
- ARWR $2,500,000.00
- RNG $2,400,395,000.00
- Revenue This Year
- ARWR $4,380.43
- RNG $6.15
- Revenue Next Year
- ARWR $64.24
- RNG $5.97
- P/E Ratio
- ARWR N/A
- RNG N/A
- Revenue Growth
- ARWR N/A
- RNG 8.99
- 52 Week Low
- ARWR $9.57
- RNG $20.59
- 52 Week High
- ARWR $30.41
- RNG $42.19
- Technical
- Relative Strength Index (RSI)
- ARWR 38.40
- RNG 36.49
- Support Level
- ARWR $9.64
- RNG $22.20
- Resistance Level
- ARWR $12.93
- RNG $23.19
- Average True Range (ATR)
- ARWR 1.18
- RNG 1.49
- MACD
- ARWR 0.18
- RNG 0.04
- Stochastic Oscillator
- ARWR 43.21
- RNG 40.15
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.